Brain Metastases Status and Immunotherapy Efficacy in Advanced Lung Cancer: A Systematic Review and Meta-Analysis

Brain Metastases Status and Immunotherapy Efficacy in Advanced Lung Cancer: A Systematic Review and Meta-Analysis

BackgroundBrain metastases (BMs) indicate poor outcomes and are commonly excluded in immunotherapy clinical trials in advanced lung cancer; moreover, the effect of BM status on immunotherapy efficacy is inconsistent and inconclusive. Therefore, we conducted a meta-analysis to assess the influence of...

Full description

Bibliographic Details
Main Authors: Hao Hu, Zhi-Yong Xu, Qian Zhu, Xi Liu, Si-Cong Jiang, Ji-Hua Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Immunology
Subjects:
brain metastases
efficacy
immunotherapy
lung cancer
programmed cell death ligand 1
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.669398/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.669398/full

Similar Items